IP Library Granted Patent US 8,481,287
Granted Patent B2
US 8,481,287 · App. 12/812,300 · Granted Jul 9, 2013

Method, vector and system for expressing polypeptides

Inventor: Mary Lynne Perille Collins (Milwaukee, WI)
Assignee: The UWM Research Foundation, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,481,287
App. No.
12/812,300
Granted
Jul 9, 2013
Kind
B2
Abstract

Disclosed herein are methods and systems for expressing a polypeptide in a Rhodospirillum species. The methods include introducing an expression vector having a nucleic acid sequence encoding the polypeptide operably linked to a puc promoter into the Rhodospirillum bacterium and growing the Rhodospirillum bacterium under conditions that allow expression of the polypeptide. Vectors for expressing a membrane polypeptide in a Rhodospirillum species are disclosed. The vectors include a puc promoter and a nucleic acid encoding a membrane polypeptide.

Claims (31)

1. A method of expressing a polypeptide in a Rhodospirillum bacterium comprising growing the Rhodospirillum bacterium comprising a nucleic acid sequence encoding the polypeptide operably linked to a promoter selected from the group consisting of SEQ ID NO: 1 and a fragment of SEQ ID NO: 1 under conditions that allow expression of the polypeptide, wherein the Rhodospirillum bacterium is Rhodospirillum rubrum H2.

2. The method of claim 1 , wherein the promoter comprises SEQ ID NO: 2.

3. The method of claim 1 , further comprising isolating the polypeptide.

4. The method of claim 3 , wherein the polypeptide is isolated by enriching for ICM.

5. The method of claim 1 , wherein the polypeptide is a membrane polypeptide.

6. The method of claim 1 , wherein the Rhodospirillum is grown under low oxygen tension.

7. The method of claim 1 , wherein the Rhodospirillum is grown in the presence of an alternative electron acceptor.

8. The method of claim 7 , wherein the alternative electron acceptor is selected from the group consisting of dimethyl sulfoxide, methionine sulfoxide, trimethylamine oxide and combinations thereof.

9. The method of claim 1 , wherein the Rhodospirillum is grown to late log phase.

10. The method of claim 1 , wherein the Rhodospirillum is grown semi-aerobically.

11. The method of claim 1 , wherein the Rhodospirillum has reduced expression of a protein natively associated with the intracytoplasmic membrane as compared to the corresponding wild-type Rhodospirillum.

12. The method of claim 11 , wherein the Rhodospirillum species has reduced expression of at least one of RC-H, RC-L, RC-M, LH-α, or LH-β.

13. The method of claim 11 , wherein the Rhodospirillum species comprises a mutation in at least one of RC-H, RC-L, RC-M, LH-α, or LH-β.

14. The method of claim 1 , wherein the nucleic acid sequence encoding the polypeptide is part of a vector.

15. A method of producing a Rhodospirillum bacterium capable of expressing a polypeptide comprising:

introducing a vector comprising a nucleic acid sequence encoding the polypeptide operably linked to a promoter selected from the group consisting of SEQ ID NO: 1 and a fragment of SEQ ID NO: 1 into the Rhodospirillum bacterium, wherein the Rhodospirillum bacterium is Rhodospirillum rubrum H2.

16. The method of claim 15 , wherein the promoter comprises SEQ ID NO: 2.

17. The method of claim 15 , wherein the polypeptide is a membrane polypeptide.

18. The method of claim 15 , wherein the Rhodospirillum has reduced ability to express a protein natively associated with the intracytoplasmic membrane as compared to the corresponding wild-type Rhodospirillum.

19. A nucleic acid encoding a membrane polypeptide operably connected to a promoter selected from the group consisting of SEQ ID NO: 1 and a fragment of SEQ ID NO: 1, wherein the membrane polypeptide is not natively associated with the promoter.

20. The nucleic acid of claim 19 , wherein the promoter comprises SEQ ID NO:2.

21. The nucleic acid of claim 19 , further comprising a terminator fragment.

22. The nucleic acid of claim 19 , wherein the nucleic acid further comprises a sequence encoding an affinity tag.

23. The nucleic acid of claim 19 , further comprising a selectable or screenable marker for selection in a Rhodospirillum.

24. The nucleic acid of claim 19 , wherein a vector comprises the nucleic acid.

25. A Rhodospirillum comprising the nucleic acid of claim 19 , wherein the Rhodospirillum is Rhodospirillum rubrum H2.

26. A system for expressing a polypeptide in a Rhodospirillum comprising the Rhodospirillum and a vector comprising a promoter selected from the group consisting of SEQ ID NO: 1 and a fragment of SEQ ID NO: 1, wherein the Rhodospirillum bacterium is Rhodospirillum rubrum H2.

27. The system of claim 26 , wherein the promoter comprises SEQ ID NO:2.

28. The system of claim 26 , wherein the polypeptide is a membrane polypeptide.

29. The system of claim 26 , wherein the Rhodospirillum has reduced ability to express a protein natively associated with the intracytoplasmic membrane as compared to the corresponding wild-type Rhodospirillum.

30. A Rhodospirillum bacterium comprising Rhodospirillum rubrum H2.

Assignments (3)
CONFIRMATORY LICENSE Recorded Feb 25, 2022
From: UNIVERSITY OF WISCONSIN MILWAUKEE
To: NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR
Reel/Frame 059104/0095 →
CONFIRMATORY LICENSE Recorded Jan 7, 2015
From: UNIVERSITY OF WISCONSIN MILWAUKEE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 034731/0107 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2010
From: PERILLE COLLINS, MARY LYNNE
To: THE UWM RESEARCH FOUNDATION, INC.
Reel/Frame 024748/0885 →
Continuity (2)
Provisional Application 61020095 · Jan 9, 2008
Related Publication 20100285528A1 · Nov 11, 2010